The global EUK 134 market size is predicted to grow from US$ 43.7 million in 2025 to US$ 152 million in 2031; it is expected to grow at a CAGR of 23.1% from 2025 to 2031.

EUK-134 is a preservative-free, multi-functional, super antioxidant and powerful free radical scavenger with self-regenerating property. It is a biomimetic of catalase and superoxide dismutase (SOD) enzyme. It protects against free radicals, DNA damages and reduces erythema. It helps prevent premature aging and scavenges superoxide free radicals, eliminates hydrogen peroxide (H2O2) and transforms ROS into water and oxygen which are beneficial for the skin. It reduces photoaging, protects the skin and its DNA from sun damage. It inhibits MMP-2, thus preserving a good ECM network. It reduces damages caused by UV and skin free radical activity.

EUK-134™ is used in prevention of DNA damage, DNA repair, anti-irritant, anti-stress, anti-inflammatory, antioxidant and sun care products. It is complementary to SPF ingredient.

Segmentation by Type

• >=98%
• >=99%

Segmentation by Application

• Serum
• Face Cream
• Others

Market by Region

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage

• Bloomage BioTechnology Corporation
• IFF
• Abcam
• Avantor
• ANECO
• Beri Pharma
• Shanghai Cosroma Biotech
• Shandong Juntai Pharmaceutical
• Chongqing donghuan technology development
• BOOKE

Key Questions Addressed in this Report

• What is the 10-year outlook for the global EUK 134 market?
• What factors are driving EUK 134 market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do EUK 134 market opportunities vary by end market size?
• How does EUK 134 break out by Type, by Application?